About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT04909424

Prevalence of Cutaneous Enterococci at Femoral Insertion Site in Transcatheter Aortic Valve Implantation (TAVI)

The general rules of antibiotic prophylaxis in surgery or interventional medicine include the choice of an antibiotic active on the bacteria most frequently encountered in surgical site infections. Th...

Lead sponsor: Clinique Pasteur•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Clinique Pasteur

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patient scheduled for aortic valve replacement by TAVI procedure with trans femoral approach
•Patient with pre-TAVI assessment performed at Clinique Pasteur
•Patient affiliated or beneficiary of a social security scheme
•Patient accepting to participate and having given his no objection

Exclusion Criteria

•TAVI procedure by non-trans femoral approach
•Protected patients: Adults under guardianship or other legal protection; Pregnant or breastfeeding woman; Hospitalized without consent.

Related studies

Prospective Long-Term Outcomes of a Standardized Ross Procedure

NCT06352671 · Aortic Valve Disease

Real World Data Collection on the INSPIRIS RESILIA Aortic Valve

NCT07120048 · Aortic Valve Disease

SAvvywire for Pacing and Procedural Hemodynamics In Transcatheter Aortic Valve Replacement Evaluation

NCT07366671 · TAVI(Transcatheter Aortic Valve Implantation), Aortic Valve Disease

J-Valve Transfemoral Pivotal Study

NCT06455787 · Aortic Valve Regurgitation, Aortic Valve Disease Mixed

Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease

NCT07267117 · Heart Valve Disease, Mitral Valve (MV) Regurgitation, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 6, 2026Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment100

Start dateJun 2021

Last updatedMar 6, 2026

Condition

Aortic Valve Disease

Locations shown

Clinique Pasteur

Toulouse

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 6, 2026Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions